levalbuterol tartrate HFA MDI

DRUG2 trials

Sponsors

Sumitomo Pharma America, Inc.

Conditions

AsthmaExercise-induced Bronchospasm

Phase 3

Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma

CompletedNCT00064389

Sumitomo Pharma America, Inc.Asthma

Start: 2003-01-31End: 2005-07-31Updated: 2012-02-22

Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB

CompletedNCT00268723

Sumitomo Pharma America, Inc.Exercise-induced Bronchospasm

Start: 2005-12-31End: 2006-02-28Updated: 2012-02-22